Detalhe da pesquisa
1.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med
; 384(11): 1003-1014, 2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730454
2.
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.
J Infect Dis
; 204(10): 1541-9, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21940420
3.
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
Nat Med
; 28(9): 1924-1932, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995954
4.
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
J Acquir Immune Defic Syndr
; 87(1): 671-679, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587505
5.
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
J Acquir Immune Defic Syndr
; 87(1): 680-687, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587510
6.
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
PLoS One
; 13(9): e0202753, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30235286
7.
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.
Clin Vaccine Immunol
; 24(11)2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28931520
8.
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.
Stat Commun Infect Dis
; 9(1)2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218117
9.
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.
J AIDS Clin Res
; 6(5)2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26587311
10.
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
Open Forum Infect Dis
; 2(3): ofv082, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26199949
11.
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial.
J Clin Invest
; 124(11): 4843-56, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25271627
12.
Phase angle of entrainment in morning- and evening-types under naturalistic conditions.
Chronobiol Int
; 26(3): 474-93, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19360491